Close
GS1 Global Healthcare Conference 2026
LiGHT 2026

London hospital uses new AI tool for cancer detection

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

MHRA Outlines New Agenda for AI...

The United Kingdomโ€™s Medicines and Healthcare products Regulatory Agency...

UK Confirms Indefinite Use of CE...

The United Kingdom government has officially confirmed the indefinite...

How to Know If You Need...

Tooth pain is one of those things that's easy...

Artificial intelligence is helping clinicians enhance the quality of colonoscopies at a London hospital. The London Clinic has become the UK’s first hospital to use GI Geniusโ„ข, a system that uses AI to detect colorectal polyps. The device acts as a second observer during colonoscopies, helping to assist doctors by identifying lesions and small abnormalities that could be a sign of cancer.

It works by analysing the video stream during the colonoscopy, using advanced AI to highlight the presence of pre-cancerous lesions with a visual marker in real-time. Its creators, medical device company Medtronic, hope it will improve diagnosis and therefore outcomes for patients with colorectal cancer.

Dr Rehan Haidry, Consultant Gastroenterologist at The London Clinic, said: โ€œWe are thrilled to introduce the GI Geniusโ„ข system at The London Clinic. The system represents an important advancement in technology and is a crucial step in the fight against colorectal cancer, supporting both patients and doctors.

โ€œThe technology is incredibly powerful and is proven to be extremely precise in identifying lesions in the colonic mucosa that can be difficult to detect. Some polyps can be very small, and during colonoscopy procedures you are examining the colon, which is five feet long, so itโ€™s vital to be as thorough and diligent as possible.

โ€œHaving a second set of eyes that can pick up the smallest change in real-time means we can focus our attention on the right places, which can be life-saving for patients.โ€ According to the WHO, colorectal cancer is the third most common type worldwide and the second cause of cancer deaths with 862,000 each year. However if detected and treated early it has a high cure rate. GI Geniusโ„ข has been approved for sale in Europe and has started clinical trials for US registration.

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

MHRA Outlines New Agenda for AI Medical Devices at AdvaMed

The United Kingdomโ€™s Medicines and Healthcare products Regulatory Agency...

UK Confirms Indefinite Use of CE Marked Medical Devices

The United Kingdom government has officially confirmed the indefinite...

How to Know If You Need a Root Canal

Tooth pain is one of those things that's easy...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป